Latest News
Nvidia Tumbles as AI Chip Selloff Deepens, Valuation Contracts
Nvidia shares fell over $7 to $200.42 as chip stocks slumped, with the Philadelphia semiconductor index down 3.6%. Despite strong AI demand and record earnings, investors are shifting focus from fundamentals to macro risks.
Parabilis Medicines Rockets 58% in Nasdaq Debut After Record $670M IPO
Parabilis Medicines (PBLS) closed at $31.60 on its first trading day, a 58% jump from the $20 IPO price, after raising $670 million.
Joby Aviation CFO's Stock Sale Triggers Share Decline
Joby Aviation shares dropped 4.47% after the CFO disclosed a prearranged stock sale. The market focused on regulatory progress and cash burn rather than any new operational updates.
YY Group Surges on Humanoid Robot Plans; Risks Remain
YY Group shares surged to $0.165 after announcing a humanoid robot project using Unitree G1 robots. The rally faces risks from a net loss, dilution, and no robot revenue.
Snap Stock Slips as Tech Selloff Intensifies Ahead of CEO's AWE Keynote
Snap shares slid 4% to $5.38, extending a three-day losing streak amid a broader tech selloff, as investors focus on ad growth challenges and CEO Evan Spiegel's upcoming AWE keynote on June 16.
Outlook Therapeutics Surges on FDA Review Progress for Lytenava
Outlook Therapeutics shares surged 26% to $0.89 as the FDA began a 60-day review of Lytenava after a successful appeal, though the stock faces Nasdaq delisting and dilution risks.
Freshworks Holds Steady as AI Restructuring Test Looms in Q2
Freshworks shares held flat near $9.39 on heavy volume, as investors weigh AI restructuring costs and Freshservice focus ahead of Q2 results.
ERock Stock Falls Below IPO Price on NYSE Debut Amid AI Power Contract Doubts
ERock (EROC) fell 12.37% in its NYSE debut, closing at $18.84 as investors worried about its $1.28B AI data-center backlog.
